Collecting data on patients activated by rapid response teams in hospitals
Official title: Prospective Cohort Study of Rapid Response Team
Run by Seoul National University Hospital · NCT02986581 · Data updated 2026-11-12
This study is tracking patients who get worse quickly in the hospital to see how well the rapid response team helps them during emergencies.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 15 Years and up |
| Sex | All |
| Enrollment | 79800 (estimated) |
| Sponsor | Seoul National University Hospital Academic / other |
| Locations | 1 site (Seongnam-si) |
| Status | Recruiting |
| Started | November 2016 |
| Main results expected | November 2022 |
| Study ends | November 2026 |
| Registry record updated | June 30, 2021 |
| Trial ID | NCT02986581 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients admitted to the general ward at Seoul National University Bundang Hospital who are monitored by the in-hospital rapid response system.
✕Probably not a fit
Patients admitted to pediatric wards, emergency rooms, intensive care units, or operating rooms may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather data on patients who experience acute deterioration, including sudden cardiac arrest, while being monitored by a rapid response team in a general ward. The study will prospectively track these patients to assess the effectiveness and response of the rapid response team. By analyzing the outcomes of these interventions, the study seeks to improve emergency care protocols within the hospital setting.
Why it matters
Potential benefit: If successful, this study could enhance the effectiveness of rapid response teams, leading to better patient outcomes in emergency situations.
How similar studies have gone: Other studies have shown success in improving patient outcomes through the implementation of rapid response teams, indicating that this approach is supported by existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Patients admitted to general ward in Seoul National University Bundang Hospital and monitored by in-hospital rapid response system. Exclusion Criteria: * patients admitted to pediatric wards * patients in emergency room, intensive care unit, and operating room
Where it's running
-
Seoul National University Bundang Hospital
Seongnam-si, South Korea Recruiting
Study contacts
- Principal investigator: Yeon Joo Lee, MD — Seoul National University Bundang Hospital
- Study coordinator: Yeon Joo Lee, MD
- Email: yjlee1117@snubh.org
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Who should lead hospital rapid response teams?
This trial will test whether a Critical Care Outreach Team led by an ICU nurse plus ward clinicians works as well as a Medical Emergency Team led by an ICU doctor for adult patients on general wards who need rapid response care.
-
Prebiotic and Probiotic Combo for Constipation Symptoms
This study tests whether adding 1-kestose to a probiotic (BBH112) helps adults with constipation-related symptoms see more relief and better quality of life.
-
Rehabilitation data registry for spinal cord injury in Korea
This study tests whether long‑term disability and function after spinal cord injury can be predicted by combining medical and socioeconomic information gathered during and after inpatient rehabilitation.
-
RSV vaccine safety and immune response in lung transplant patients vs. healthy adults
This study tests how well the RSV vaccine works and how safe it is in people who have had a lung transplant compared with healthy adults.
-
CD19 CAR-T Therapy for Kids with Refractory Childhood SLE
This study tests whether a patient’s own CD19 CAR-T cells can help children and young adults with severe, hard-to-treat lupus.
-
Remimazolam vs propofol for stable blood pressure during thoracic/abdominal endovascular aortic repair
This trial tests whether remimazolam keeps blood pressure steadier than propofol during TEVAR or EVAR in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.